SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001021771-19-000061
Filing Date
2019-10-10
Accepted
2019-10-10 17:26:04
Documents
4
Period of Report
2019-10-07
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K OCTOBER 7, 2019 form8k100719.htm 8-K 22899
2 CONVERTIBLE PROM NOTE exhibit10_1.htm EX-10.1 96839
3 WARRANT exhibit10_2.htm EX-10.2 54730
4 image00001.jpg GRAPHIC 8238
  Complete submission text file 0001021771-19-000061.txt   187326
Mailing Address 40 MARCUS DRIVE MELVILLE NY 11747
Business Address 40 MARCUS DRIVE MELVILLE NY 11747 (631) 760-8100
BioRestorative Therapies, Inc. (Filer) CIK: 0001505497 (see all company filings)

IRS No.: 911835664 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37603 | Film No.: 191146714
SIC: 8090 Services-Misc Health & Allied Services, NEC